Landmark mediation survival analysis using longitudinal surrogate

Jie Zhou(Cleveland Clinic), Peng Wei(Creighton University), Brian P. Hobbs(Tellabs (Canada)), H. Amy Xia(Xiangyang Central Hospital), Xun Jiang

Frontiers in Oncology

January 17, 2023

10.3389/fonc.2022.999324

Cited by 2

Related Papers

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies

|Human Molecular Genetics|2014|1.2k

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial

|The Lancet|2015|518

Use of historical control data for assessing treatment effects in clinical trials

|Pharmaceutical Statistics|2013|505

Gut commensal <i>Parabacteroides distasonis</i> alleviates inflammatory arthritis

|Gut|2023|237

Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases

|American Journal of Epidemiology|2017|218